![Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines](https://www.mdpi.com/cancers/cancers-12-00577/article_deploy/html/images/cancers-12-00577-g005.png)
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
![Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | bioRxiv Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/01/28/2020.01.27.921312/F3.large.jpg)
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | bioRxiv
YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice | Oncotarget
![Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | bioRxiv Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/01/28/2020.01.27.921312/F4.large.jpg)
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | bioRxiv
![A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer - Annals of Oncology A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/cc5074e0-0193-4b14-ba0c-fbd8ea9ac285/gr1.jpg)
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer - Annals of Oncology
![Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-47573-y/MediaObjects/41598_2019_47573_Fig2_HTML.png)
Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports
![Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-47573-y/MediaObjects/41598_2019_47573_Fig5_HTML.png)
Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports
![Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines](https://www.mdpi.com/cancers/cancers-12-00577/article_deploy/html/images/cancers-12-00577-g004.png)
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
![Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines](https://www.mdpi.com/cancers/cancers-12-00577/article_deploy/html/images/cancers-12-00577-g002.png)
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
![Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is mediated by time-dependent inhibition of the NF-κB pathway | Scientific Reports Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is mediated by time-dependent inhibition of the NF-κB pathway | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-28213-3/MediaObjects/41598_2018_28213_Fig1_HTML.jpg)
Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is mediated by time-dependent inhibition of the NF-κB pathway | Scientific Reports
![YM155 and BIRC5 downregulation induce genomic instability via autophagy-mediated ROS production and inhibition in DNA repair - ScienceDirect YM155 and BIRC5 downregulation induce genomic instability via autophagy-mediated ROS production and inhibition in DNA repair - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S104366182100058X-ga1.jpg)
YM155 and BIRC5 downregulation induce genomic instability via autophagy-mediated ROS production and inhibition in DNA repair - ScienceDirect
![JCM | Free Full-Text | Epigenetic Changes at the Birc5 Promoter Induced by YM155 in Synovial Sarcoma | HTML JCM | Free Full-Text | Epigenetic Changes at the Birc5 Promoter Induced by YM155 in Synovial Sarcoma | HTML](https://www.mdpi.com/jcm/jcm-08-00408/article_deploy/html/images/jcm-08-00408-g009.png)